NCT04446871View on ClinicalTrials.gov

Methylene Blue in Early Septic Shock

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 17, 2017

Primary Completion Date

December 10, 2020

Study Completion Date

January 25, 2021

Conditions
Septic Shock
Interventions
DRUG

0.9% sodium chloride

Intravenous infusion of 500 cc of 0.9% sodium chloride solution for 6 h, once a day for a total of 3 doses.

DRUG

Methylene Blue

Intravenous infusion of 100 mg methylene blue in 500 cc of 0.9% sodium chloride solution for 6 h, once a day for a total of 3 doses.

Trial Locations (1)

44280

Hospital Civil Fray Antonio Alcalde, Guadalajara

All Listed Sponsors
lead

Hospital Civil de Guadalajara

OTHER

NCT04446871 - Methylene Blue in Early Septic Shock | Biotech Hunter | Biotech Hunter